Heron Therapeutics (HRTX) Asset Utilization Ratio (2011 - 2026)

Heron Therapeutics has reported Asset Utilization Ratio for 12 years, with the latest figure at 0.6 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 5.23% year-over-year to 0.6; the trailing twelve-month figure through Mar 2026 stood at 0.6 (down 5.23% YoY), and the FY2025 full-year result was 0.63, changed 0.03% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.6, down from 0.61 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.64 in Q3 2025, with the low at 0.31 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.55 across 5 years, with a median of 0.6 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 67.06% — and 2026, when it declined 5.23%.
• Heron Therapeutics' Asset Utilization Ratio stood at 0.41 in 2022, then jumped by 36.59% to 0.56 in 2023, then climbed by 13.02% to 0.64 in 2024, then fell by 3.47% to 0.61 in 2025, then decreased by 2.18% to 0.6 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.6 (Q1 2026), 0.61 (Q4 2025), and 0.64 (Q3 2025), per Business Quant data.